Superficial transitional cell carcinoma of the bladder

Management and prognosis

Murugesan Manoharan, Mark S. Soloway

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)
Original languageEnglish
Title of host publicationUrologic Oncology
PublisherElsevier Inc.
Pages317-337
Number of pages21
ISBN (Print)9780721600031
DOIs
StatePublished - Dec 1 2005

Fingerprint

Transitional Cell Carcinoma
Urinary Bladder

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Manoharan, M., & Soloway, M. S. (2005). Superficial transitional cell carcinoma of the bladder: Management and prognosis. In Urologic Oncology (pp. 317-337). Elsevier Inc.. https://doi.org/10.1016/B978-0-7216-0003-1.50021-6

Superficial transitional cell carcinoma of the bladder : Management and prognosis. / Manoharan, Murugesan; Soloway, Mark S.

Urologic Oncology. Elsevier Inc., 2005. p. 317-337.

Research output: Chapter in Book/Report/Conference proceedingChapter

Manoharan, Murugesan ; Soloway, Mark S. / Superficial transitional cell carcinoma of the bladder : Management and prognosis. Urologic Oncology. Elsevier Inc., 2005. pp. 317-337
@inbook{b724f9af37be40ceb7bb4a9633aff5b3,
title = "Superficial transitional cell carcinoma of the bladder: Management and prognosis",
author = "Murugesan Manoharan and Soloway, {Mark S.}",
year = "2005",
month = "12",
day = "1",
doi = "10.1016/B978-0-7216-0003-1.50021-6",
language = "English",
isbn = "9780721600031",
pages = "317--337",
booktitle = "Urologic Oncology",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Superficial transitional cell carcinoma of the bladder

T2 - Management and prognosis

AU - Manoharan, Murugesan

AU - Soloway, Mark S.

PY - 2005/12/1

Y1 - 2005/12/1

UR - http://www.scopus.com/inward/record.url?scp=67349182818&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67349182818&partnerID=8YFLogxK

U2 - 10.1016/B978-0-7216-0003-1.50021-6

DO - 10.1016/B978-0-7216-0003-1.50021-6

M3 - Chapter

SN - 9780721600031

SP - 317

EP - 337

BT - Urologic Oncology

PB - Elsevier Inc.

ER -